You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple myeloma with amyloid deposition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Samples and Clinical Data From Patients With Amyloid Diseases

Recruiting
  • Multiple Myeloma
  • clonality analysis
  • +6 more
  • Boston, Massachusetts
    Boston University Cancer Research Center
Jan 28, 2023

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

Recruiting
  • Multiple Myeloma
  • +8 more
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital
    Nov 30, 2021

    A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

    Recruiting
    • Multiple Myeloma
    • +11 more
    • No intervention
    • Beijing, China
      Peking University First Hospital
    Apr 21, 2022

    Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

    Active, not recruiting
    Has Results
    • Primary Systemic Amyloidosis
    • Light Chain Deposition Disease
    • Denver, Colorado
    • +6 more
    Aug 24, 2022

    Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Myeloma-Associated Amyloidosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 6, 2023

    Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

    Suspended
    • Amyloid
    • +2 more
    • New York, New York
      Weill Cornell Medicine - Multiple Myeloma Center
    May 17, 2022

    Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

    Recruiting
    • Amyloidosis, Primary
    • Cardiomyopathy
    • F-18 florbetapir/C-11 acetate PET
    • +2 more
    • Boston, Massachusetts
      Brigham and Womens' Hospital
    Oct 23, 2022

    Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)

    Completed
    • Alzheimer Disease
    • Cognitive Decline
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 28, 2022

    Light Chain Deposition Disease (LCDD or MIDD), Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD), Monoclonal

    Completed
    Has Results
    • Light Chain Deposition Disease (LCDD or MIDD)
    • +3 more
    • Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
    • Basking Ridge, New Jersey
    • +4 more
    Mar 30, 2020

    Heart Failure With Preserved Ejection Fraction, Amyloidosis Cardiac Trial in Taipei (NA, observational study)

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Amyloidosis Cardiac
    • NA, observational study
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 8, 2022

    Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)

    Recruiting
    • Tauopathies
    • Amyloid PET scan
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Oct 14, 2023

    Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

    Completed
    Has Results
    • Alzheimer Disease
    • Transcranial Alternating Current Stimulation (tACS)
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Feb 2, 2022

    Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Renal Significance
    • Basking Ridge, New Jersey
    • +6 more
    Oct 16, 2023

    High Frequency Imaging in Cerebral Amyloid Angiopathy

    Recruiting
    • Cerebral Amyloid Angiopathy
    • MR Imaging
    • Bonn, Germany
    • +2 more
    Nov 7, 2023

    Early Diagnosis of SCD Based on Radiogenomics

    Recruiting
    • Alzheimer Disease
    • +3 more
    • Multiple features extraction
    • Beijing, Beijing, China
      Department of Neurolgy, Xuanwu Hospital of Capital Medical Unive
    Jul 12, 2022

    Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Nantes Cedex 1, France
    • +19 more
    Aug 11, 2022

    BEAM: Brain-Eye Amyloid Memory Study

    Recruiting
    • Alzheimer's Disease
    • +4 more
    • Pittsburgh Compound B [11C]-PIB
    • Toronto, Ontario, Canada
    • +4 more
    Oct 24, 2022

    Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

    Recruiting
    • Cognitively Normal Older Adults
    • +3 more
    • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
    • PCP
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Mild Cognitive Impairment, Healthy, Alzheimer Trial in Schlieren (18F-AV-1451 (Tau-PET tracer))

    Active, not recruiting
    • Mild Cognitive Impairment
    • +3 more
    • 18F-AV-1451 (Tau-PET tracer)
    • Schlieren, Zurich, Switzerland
      Institute for Regenerative Medicine (IREM)
    Dec 21, 2021

    Project in First-degree Relatives of Myeloma Patient - The

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Sample of Blood
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 31, 2023

    Sleep Aging and Risk for Alzheimer's 2.0

    Recruiting
    • Alzheimer Disease
    • Sleep Apnea
    • PET Scan and nocturnal polysomnography
    • New York, New York
      Healthy Brain Aging and Sleep Center
    Oct 27, 2022

    OCTA Factors in or Without Amyloid Pathology: A Prospective

    Completed
    • Alzheimer Disease
    • +4 more
      • Busan, Korea, Republic of
        Pusan National University Hospital
      Jul 24, 2022

      Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome

      Recruiting
      • Transthyretin Amyloidosis
      • Carpal Tunnel Syndrome
      • Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
      • Porto, Portugal
        Centro Hospitalar Universitário São João
      Jan 12, 2023